Hearing: Improving Predictability and Transparency in DEA and FDA Regulation

Subcommittee on Health (Committee on Energy and Commerce)

Monday, April 7, 2014 (3:00 PM)

2123 RHOB
Washington, D.C.

Witnesses

Panel one

Mr. Joseph T. Rannazzisi
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Control, U.S. Department of Justice, Springfield, VA

Added 04/04/2014 at 10:42 AM
  • Witness Statement [PDF] Added 04/05/2014 at 01:24 PM
  • Questions for the Record letter [PDF] Added 07/09/2014 at 03:22 PM
  • QFR Response [PDF] Added 05/01/2015 at 04:19 PM
  • Witness Truth in Testimony [PDF] Added 04/04/2014 at 02:59 PM
  • Witness Biography [PDF] Added 04/04/2014 at 02:59 PM

Panel two

Mr. D. Linden Barber
Partner and Director, DEA Compliance Practice, Quarles & Brady LLP, Washington, D.C.

Added 04/04/2014 at 10:42 AM
  • Witness Statement [PDF] Added 04/04/2014 at 03:36 PM
  • Questions for the Record letter [PDF] Added 07/09/2014 at 03:22 PM
  • Questions for the Record response [PDF] Added 07/09/2014 at 03:22 PM
  • Witness Truth in Testimony [PDF] Added 04/04/2014 at 02:59 PM
  • Witness Biography [PDF] Added 04/04/2014 at 02:59 PM

Mr. Scott Faber
Vice President of Government Affairs, Environmental Working Group, Washington, D.C.

Added 04/04/2014 at 02:59 PM
  • Witness Statement [PDF] Added 04/06/2014 at 06:20 PM
  • Witness Truth in Testimony [PDF] Added 04/07/2014 at 09:04 AM
  • Witness Biography [PDF] Added 04/07/2014 at 09:04 AM

Dr. Nathan B. Fountain
Professor of Neurology and Director, F.E. Dreifuss Comprehensive Epilepsy Program, University of Virginia, Charlottesville, VA

Added 04/04/2014 at 10:42 AM
  • Witness Statement [PDF] Added 04/04/2014 at 02:59 PM
  • Witness Truth in Testimony [PDF] Added 04/04/2014 at 02:59 PM
  • Witness Biography [PDF] Added 04/04/2014 at 03:36 PM

Mr. John M. Gray
President and CEO, Healthcare Distribution Management Association, Arlington, VA

Added 04/04/2014 at 10:42 AM
  • Witness Statement [PDF] Added 04/04/2014 at 02:59 PM
  • Witness Truth in Testimony [PDF] Added 04/04/2014 at 02:59 PM
  • Witness Biography [PDF] Added 04/04/2014 at 02:59 PM

Ms. Wendy K.D. Selig
President and CEO, Melanoma Research Alliance, Washington, D.C.

Added 04/04/2014 at 10:42 AM
  • Witness Statement [PDF] Added 04/04/2014 at 04:59 PM
  • Witness Truth in Testimony [PDF] Added 04/04/2014 at 04:59 PM
  • Witness Biography [PDF] Added 04/04/2014 at 04:59 PM

Dr. Janet Woodcock
Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD

Added 04/04/2014 at 10:42 AM
  • Witness Statement [PDF] Added 04/04/2014 at 02:59 PM
  • Questions for the Record Enclosure [PDF] Added 07/09/2014 at 03:22 PM
  • Questions for the Record Response [PDF] Added 01/09/2015 at 01:21 PM
  • Witness Truth in Testimony [PDF] Added 04/04/2014 at 02:59 PM
  • Witness Biography [PDF] Added 04/04/2014 at 02:59 PM

Text of Legislation

  • H.R. 4299, the "Improving Regulatory Transparency for New Medical Therapies Act" [PDF]
  • H.R. 4069, the "Ensuring Patient Access and Effective Drug Enforcement Act" [PDF]
  • H.R. 4250, the "Sunscreen Innovation Act" [PDF]

Support Documents

  • Hearing Notice [PDF]
  • Hearing Memo [PDF] Added 04/04/2014 at 10:37 AM
  • Opening Statement by Subcommittee Chairman Pitts [PDF] Added 04/07/2014 at 05:11 PM
  • Opening Statement of Committee Chairman Upton [PDF] Added 04/07/2014 at 05:11 PM
  • Document for the Record, AADA [PDF] Added 04/07/2014 at 05:11 PM
  • Document for the Record, APAM [PDF] Added 04/07/2014 at 05:11 PM
  • Document for the Record, DPA [PDF] Added 04/07/2014 at 05:11 PM
  • Document for the Record, Fed Ex [PDF] Added 04/07/2014 at 05:11 PM
  • Document for the Record, GHLF [PDF] Added 04/07/2014 at 05:11 PM
  • Document for the Record, NACDS [PDF] Added 04/07/2014 at 05:11 PM
  • Attendance [PDF] Added 04/08/2014 at 10:54 AM

Hearing Record

  • Hearing Transcript [PDF] Added 04/14/2014 at 04:32 PM

First Published: March 31, 2014 at 05:22 PM
Last Updated: May 1, 2015 at 04:19 PM